x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
Delaware
|
86-0629024
|
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
(IRS
Employer Identification No.)
|
Large
Accelerated Filer x
|
Accelerated
filer ¨
|
Non-accelerated
filer ¨
|
Shares
Outstanding of Registrant’s Common Stock
|
|
Class
|
Outstanding
at July 31, 2007
|
Common
Stock, $0.001 par value
|
218,763,159
shares
|
Page
|
||
PART
I. FINANCIAL INFORMATION
|
||
Item
1.
|
Financial
Statements (Unaudited)
|
|
Item
2.
|
||
Item
3.
|
||
Item
4.
|
||
PART
II. OTHER INFORMATION
|
||
Item
1.
|
||
Item
1A.
|
||
Item
6.
|
||
CERTIFICATIONS
|
||
EXHIBITS
|
ASSETS
|
|||||||||
June
30,
|
March
31,
|
||||||||
2007
|
2007
|
||||||||
(Unaudited)
|
(Note
1)
|
||||||||
Cash
and cash equivalents
|
$ |
168,003
|
$ |
167,477
|
|||||
Short-term
investments
|
553,569
|
583,000
|
|||||||
Accounts
receivable, net
|
127,320
|
124,559
|
|||||||
Inventories
|
123,767
|
121,024
|
|||||||
Prepaid
expenses
|
18,547
|
15,547
|
|||||||
Deferred
tax assets
|
63,270
|
61,983
|
|||||||
Other
current assets
|
29,610
|
11,147
|
|||||||
Total
current
assets
|
1,084,086
|
1,084,737
|
|||||||
Property,
plant and equipment, net
|
604,772
|
605,722
|
|||||||
Long-term
investments
|
621,909
|
527,910
|
|||||||
Goodwill
|
31,886
|
31,886
|
|||||||
Intangible
assets, net
|
8,376
|
8,456
|
|||||||
Other
assets
|
11,313
|
10,830
|
|||||||
Total
assets
|
$ |
2,362,342
|
$ |
2,269,541
|
|||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||||
Accounts
payable
|
$ |
48,472
|
$ |
34,675
|
|||||
Accrued
liabilities
|
47,882
|
129,882
|
|||||||
Deferred
income on shipments to distributors
|
89,932
|
91,363
|
|||||||
Total
current
liabilities
|
186,286
|
255,920
|
|||||||
Long-term
income tax payable
|
107,890
|
---
|
|||||||
Deferred
tax liability
|
6,186
|
8,327
|
|||||||
Other
long-term liabilities
|
936
|
926
|
|||||||
Stockholders’
equity:
|
|||||||||
Preferred
stock, $0.001 par value; authorized 5,000,000 shares;
|
|||||||||
no
shares issued or
outstanding.
|
---
|
---
|
|||||||
Common
stock, $0.001 par value; authorized 450,000,000 shares;
|
|||||||||
issued
and outstanding
218,613,509 shares at June 30, 2007;issued and outstanding 217,439,960
shares
|
219
|
217
|
|||||||
at March 31, 2007. | |||||||||
Additional
paid-in capital
|
794,356
|
755,834
|
|||||||
Retained
earnings
|
1,274,660
|
1,255,486
|
|||||||
Accumulated
other comprehensive loss
|
(8,191 | ) | (7,169 | ) | |||||
Net
stockholders’
equity
|
2,061,044
|
2,004,368
|
|||||||
Total
liabilities and
stockholders’ equity
|
$ |
2,362,342
|
$ |
2,269,541
|
|||||
See
accompanying notes to condensed consolidated financial
statements
|
Three
Months Ended June 30,
|
|||||||||
2007
|
2006
|
||||||||
Net
sales
|
$ |
264,072
|
$ |
262,557
|
|||||
Cost
of sales (1)
|
105,527
|
104,073
|
|||||||
Gross
profit
|
158,545
|
158,484
|
|||||||
Operating
expenses:
|
|||||||||
Research
and development (1)
|
29,746
|
28,024
|
|||||||
Selling,
general and administrative (1)
|
43,780
|
40,779
|
|||||||
73,526
|
68,803
|
||||||||
Operating
income
|
85,019
|
89,681
|
|||||||
Other
income (expense):
|
|||||||||
Interest
income
|
14,902
|
13,927
|
|||||||
Interest
expense
|
---
|
(2,489 | ) | ||||||
Other,
net
|
822
|
176
|
|||||||
Income
before income taxes
|
100,743
|
101,295
|
|||||||
Income
tax provision
|
20,450
|
24,311
|
|||||||
Net
income
|
$ |
80,293
|
$ |
76,984
|
|||||
Basic
net income per common share
|
$ |
0.37
|
$ |
0.36
|
|||||
Diluted
net income per common share
|
$ |
0.36
|
$ |
0.35
|
|||||
Dividends
declared per common share
|
$ |
0.280
|
$ |
0.215
|
|||||
Basic
common shares outstanding
|
218,111
|
214,175
|
|||||||
Diluted
common shares outstanding
|
223,592
|
219,791
|
|||||||
(1)
Includes share-based compensation expense as follow:
|
|||||||||
Cost
of sales
|
$ |
1,590
|
$ |
---
|
|||||
Research
and development
|
2,586
|
2,291
|
|||||||
Selling,
general and administrative
|
3,857
|
3,514
|
|||||||
See
accompanying notes to condensed consolidated financial
statements
|
Three
months ended June 30,
|
|||||||||
2007
|
2006
|
||||||||
Cash
flows from operating activities:
|
|||||||||
Net
income
|
$ |
80,293
|
$ |
76,984
|
|||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
|||||||||
Depreciation
and amortization
|
26,898
|
28,519
|
|||||||
Deferred
income taxes
|
(3,087 | ) | (1,410 | ) | |||||
Share-based compensation expense related to equity incentive
plans
|
8,033
|
5,805
|
|||||||
Excess
tax benefit from share-based compensation
|
(8,674 | ) | (7,114 | ) | |||||
Tax
benefit from equity incentive plans
|
8,767
|
7,117
|
|||||||
Gain
on sale of assets
|
(450 | ) | (299 | ) | |||||
Changes
in operating assets and liabilities:
|
|||||||||
(Increase)
decrease in accounts receivable
|
(2,761 | ) |
2,165
|
||||||
(Increase)
decrease in inventories
|
(2,709 | ) |
49
|
||||||
(Decrease)
increase in deferred income on shipments to distributors
|
(1,431 | ) |
11,430
|
||||||
Increase
in accounts payable and accrued liabilities
|
23,148
|
5,754
|
|||||||
Change
in other assets and liabilities
|
(5,397 | ) |
803
|
||||||
Net
cash provided by operating activities
|
122,630
|
129,803
|
|||||||
Cash
flows from investing activities:
|
|||||||||
Purchases
of investments
|
(531,291 | ) | (931,254 | ) | |||||
Sales
and maturities of investments
|
465,360
|
541,952
|
|||||||
Investment
in other assets
|
(398 | ) | (219 | ) | |||||
Proceeds
from sale of assets
|
450
|
673
|
|||||||
Capital
expenditures
|
(25,470 | ) | (16,645 | ) | |||||
Net
cash used in investing activities
|
(91,349 | ) | (405,493 | ) | |||||
Cash
flows from financing activities:
|
|||||||||
Payment
of cash dividend
|
(61,119 | ) | (46,064 | ) | |||||
Proceeds
from sale of common stock
|
21,690
|
17,477
|
|||||||
Excess
tax benefit from share-based compensation
|
8,674
|
7,114
|
|||||||
Payments
on short-term borrowings
|
---
|
(131,454 | ) | ||||||
Net
cash used in financing activities
|
(30,755 | ) | (152,927 | ) | |||||
Net
increase (decrease) in cash and cash equivalents
|
526
|
(428,617 | ) | ||||||
Cash
and cash equivalents at beginning of period
|
167,477
|
565,273
|
|||||||
Cash
and cash equivalents at end of period
|
$ |
168,003
|
$ |
136,656
|
|||||
See
accompanying notes to condensed consolidated financial
statements
|
(1)
|
Basis
of Presentation
|
(2)
|
Recently
Issued Accounting
Pronouncements
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
|||||||||||||
Government
agency bonds
|
$ |
705,946
|
$ |
14
|
$ |
9,309
|
$ |
696,651
|
||||||||
Floating
rate securities
|
325,650
|
---
|
258
|
325,392
|
||||||||||||
Municipal
bonds
|
88,998
|
---
|
456
|
88,542
|
||||||||||||
Corporate
bonds and certificates of deposit
|
65,000
|
---
|
107
|
64,893
|
||||||||||||
$ |
1,185,594
|
$ |
14
|
$ |
10,130
|
$ |
1,175,478
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
|||||||||||||
Available-for-sale
|
||||||||||||||||
Due
in one year or
less
|
$ |
206,400
|
$ |
---
|
$ |
1,510
|
$ |
204,890
|
||||||||
Due
after one year and through
five years
|
684,678
|
14
|
8,504
|
676,188
|
||||||||||||
Due
after five years and
through ten years
|
15,625
|
---
|
48
|
15,577
|
||||||||||||
Due
after ten
years
|
278,891
|
---
|
68
|
278,823
|
||||||||||||
$ |
1,185,594
|
$ |
14
|
$ |
10,130
|
$ |
1,175,478
|
(4)
|
Accounts
Receivable
|
June
30,
2007
|
March
31,
2007
|
||||||
Trade
accounts receivable
|
$ |
130,005
|
$ |
127,467
|
|||
Other
|
712
|
636
|
|||||
130,717
|
128,103
|
||||||
Less
allowance for doubtful accounts
|
3,397
|
3,544
|
|||||
$ |
127,320
|
$ |
124,559
|
(5)
|
Inventories
|
June
30,
2007
|
March
31,
2007
|
||||||
Raw
materials
|
$ |
5,092
|
$ |
5,118
|
|||
Work
in process
|
90,239
|
83,783
|
|||||
Finished
goods
|
28,436
|
32,123
|
|||||
$ |
123,767
|
$ |
121,024
|
(6)
|
Property,
Plant and Equipment
|
June
30,
2007
|
March
31,
2007
|
||||||
Land
|
$ |
47,212
|
$ |
47,212
|
|||
Building
and building improvements
|
373,419
|
372,149
|
|||||
Machinery
and equipment
|
1,076,577
|
1,059,565
|
|||||
Projects
in process
|
73,998
|
69,040
|
|||||
1,571,206
|
1,547,966
|
||||||
Less
accumulated depreciation and
amortization
|
966,434
|
942,244
|
|||||
$ |
604,772
|
$ |
605,722
|
(8)
|
Comprehensive
Income
|
Three
Months Ended
June
30,
|
||
2007
|
2006
|
|
Increase
in unrealized losses on investments, net of tax effect of
$341, and $385,
respectively
|
$ 1,022
|
$ 1,367
|
(9)
|
Employee
Benefit Plans
|
Three
Months Ended June 30,
|
|||||||
2007
|
2006
|
||||||
Cost
of sales
|
$ | 1,590 | (1) | $ | --- | (1) | |
Research
and development
|
2,586
|
2,291
|
|||||
Selling,
general and administrative
|
3,857
|
3,514
|
|||||
Pre-tax
effect of share-based compensation
|
8,033
|
5,805
|
|||||
Income
tax benefit
|
1,631
|
1,393
|
|||||
Net
income effect of share-based compensation
|
$ |
6,402
|
$ |
4,412
|
|||
Effect
on net income per common share – basic and diluted
|
$ |
0.03
|
$ |
0.02
|
Number
of Shares
|
|||
Nonvested
shares at March 31, 2007
|
1,687,443
|
||
Granted
|
265,690
|
||
Cancelled
|
(23,310 | ) | |
Vested
|
(31,681 | ) | |
Nonvested
shares at June 30, 2007
|
1,898,142
|
Number
of
Shares
|
Weighted
Average
Exercise
Price
per Share
|
||||||
Outstanding
at March 31, 2007
|
14,740,546
|
$ |
21.88
|
||||
Granted
|
1,793
|
37.36
|
|||||
Exercised
|
(1,120,597 | ) |
18.81
|
||||
Cancelled
|
(47,122 | ) |
23.97
|
||||
Outstanding
at June 30, 2007
|
13,574,620
|
$ |
22.13
|
Range
of Exercise Prices
|
Number
of Outstanding
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Life
|
Number
Exercisable
|
Weighted
Average
Exercise
Price
|
||||||||||||
(in
years)
|
|||||||||||||||||
$ |
4.72 – $10.04
|
1,396,376
|
$ |
8.92
|
1.52
|
1,396,376
|
$ |
8.92
|
|||||||||
10.05 – 15.92
|
1,301,890
|
15.64
|
3.61
|
1,301,890
|
15.64
|
||||||||||||
15.93 – 18.48
|
1,840,791
|
18.40
|
5.59
|
890,451
|
18.32
|
||||||||||||
18.49 – 23.39
|
1,634,172
|
22.38
|
3.32
|
1,633,993
|
22.38
|
||||||||||||
23.40 – 25.26
|
920,374
|
24.19
|
4.89
|
918,829
|
24.19
|
||||||||||||
25.27 – 25.29
|
1,636,492
|
25.29
|
7.74
|
22,377
|
25.29
|
||||||||||||
25.30 – 27.00
|
726,382
|
26.22
|
6.48
|
688,123
|
26.21
|
||||||||||||
27.01 – 27.05
|
1,437,267
|
27.05
|
6.74
|
54,687
|
27.05
|
||||||||||||
27.06 – 27.15
|
1,613,174
|
27.15
|
4.75
|
1,613,174
|
27.15
|
||||||||||||
27.16 – 37.36
|
1,067,702
|
29.78
|
6.34
|
760,540
|
29.45
|
||||||||||||
13,574,620
|
$ |
22.13
|
5.05
|
9,280,440
|
$ |
20.93
|
Three
Months Ended
June
30,
|
Three
Months Ended
June
30,
|
||||||
2007
|
2006
|
||||||
Expected
life (in years)
|
6.50
|
5.39
|
|||||
Expected
volatility
|
39 | % | 42 | % | |||
Risk-free
interest rate
|
5.03 | % | 5.25 | % | |||
Expected
dividend yield
|
3.00 | % | 3.00 | % |
Three
Months Ended June 30,
|
|||||||
2007
|
2006
|
||||||
Expected
life (in years)
|
0.50
|
0.50
|
|||||
Expected
volatility
|
26
|
% | 29 | % | |||
Risk-free
interest rate
|
4.95 | % | 5.25 | % | |||
Expected
dividend yield
|
3.00 | % | 3.00 | % |
(10)
|
Net
Income Per Share
|
Three
Months Ended
June
30,
|
|||||||
2007
|
2006
|
||||||
Net
income
|
$ |
80,293
|
$ |
76,984
|
|||
Weighted
average common shares outstanding
|
218,111
|
214,175
|
|||||
Dilutive
effect of stock options
|
5,481
|
5,616
|
|||||
Weighted
average common and potential common shares outstanding
|
223,592
|
219,791
|
|||||
Basic
net income per common share
|
$ |
0.37
|
$ |
0.36
|
|||
Diluted
net income per common share
|
$ |
0.36
|
$ |
0.35
|
(11)
|
Stock
Repurchase
|
(12)
|
Dividends
|
|
·
|
The
effects and amount of competitive pricing pressure on our product
lines;
|
|
·
|
Our
ability to moderate future average selling price
declines;
|
|
·
|
The
effect of product mix on gross
margin;
|
|
·
|
The
amount of changes in demand for our products and those of our
customers;
|
|
·
|
The
level of orders that will be received and shipped within a
quarter;
|
|
·
|
The
effect that distributor and customer inventory holding patterns
will have
on us;
|
|
·
|
Our
belief that customers recognize our products and brand name and
use
distributors as an effective supply
channel;
|
|
·
|
Our
belief that our direct sales personnel combined with out distributors
provide an effective means of reaching our customer
base;
|
|
·
|
Our
ability to increase the proprietary portion of our analog and interface
product lines and the effect of such an
increase;
|
|
·
|
The
impact of any supply disruption we may
experience;
|
|
·
|
Our
ability to effectively utilize our facilities at appropriate capacity
levels and anticipated costs;
|
|
·
|
That
our capital expenditures over the next 12 months will provide sufficient
manufacturing capability to meet our anticipated
needs;
|
|
·
|
That
manufacturing costs will be reduced by our transition to advanced
process
technologies;
|
|
·
|
Our
ability to maintain manufacturing
yields;
|
|
·
|
Continuing
our investments in new and enhanced
products;
|
|
·
|
The
ability to attract and retain qualified
personnel;
|
|
·
|
The
cost effectiveness of using our own assembly and test
operations;
|
|
·
|
Our
anticipated level of capital
expenditures;
|
|
·
|
Continuing
to receive patents on our
inventions;
|
|
·
|
Continuation
of quarterly cash dividends;
|
|
·
|
The
sufficiency of our existing sources of
liquidity;
|
|
·
|
The
impact of seasonality on our
business;
|
|
·
|
Expected
impact of SFAS 123R on our business and related assumptions used
in such
analysis;
|
|
·
|
That
the resolution and costs of legal actions will not harm our
business;
|
|
·
|
That
the idling of assets will not impair the value of such
assets;
|
|
·
|
The
recoverability of our deferred tax
assets;
|
|
·
|
The
adequacy of our tax reserves to offset any potential tax
liabilities;
|
|
·
|
Our
belief that the expiration of any tax holidays will not have a
material
impact;
|
|
·
|
The
ability to obtain title to land underlying our Thailand facility,
its fair
value and adequacy of associated
reserves;
|
|
·
|
The
accuracy of our estimates of the useful life and values of our
property
and equipment;
|
|
·
|
Our
ability to obtain intellectual property licenses and minimize the
effects
of litigation;
|
|
·
|
The
level of risk we are exposed to for product liability
claims;
|
|
·
|
The
amount of labor unrest, political instability, governmental interference
and changes in general economic conditions that we
experience;
|
|
·
|
The
effect of changes in market interest rates on income and/or cash
flows;
|
|
·
|
The
effect of fluctuations in currency
rates;
|
|
·
|
The
timing and amount of repurchases of our common
stock:
|
|
·
|
The
availability of financing on acceptable
terms;
|
|
·
|
The
effect of expansion of environmental laws;
and
|
|
·
|
The
impact of export regulations on our
business.
|
Three
Months Ended
June
30,
|
|||||||
2007
|
2006
|
||||||
Net
sales
|
100.0 | % | 100.0 | % | |||
Cost
of sales
|
40.0 | % | 39.6 | % | |||
Gross
profit
|
60.0 | % | 60.4 | % | |||
Research
and development
|
11.3 | % | 10.7 | % | |||
Selling,
general and administrative
|
16.5 | % | 15.5 | % | |||
Operating
income
|
32.2 | % | 34.2 | % |
|
·
|
increasing
demand for our products;
|
|
·
|
increasing
semiconductor content in our customers’
products;
|
|
·
|
customers’
increasing needs for the flexibility offered by our programmable
solutions;
|
|
·
|
our
new product offerings that have increased our served available
market;
|
|
·
|
economic
conditions in the markets we serve;
and
|
|
·
|
inventory
holding patterns of our customers.
|
Three
Months Ended June 30,
(unaudited)
|
|||||||||||||||
2007
|
%
|
2006
|
%
|
||||||||||||
Microcontrollers
|
$ |
213,304
|
80.8 | % | $ |
211,316
|
80.5 | % | |||||||
Memory
products
|
30,291
|
11.5 | % |
30,607
|
11.7 | % | |||||||||
Analog
and interface products
|
20,477
|
7.7 | % |
20,634
|
7.8 | % | |||||||||
Total
sales
|
$ |
264,072
|
100.0 | % | $ |
262,557
|
100.0 | % |
Three
Months Ended
June
30,
(unaudited)
|
|||||||||||||||
2007
|
%
|
2006
|
%
|
||||||||||||
Americas
|
$ |
70,406
|
26.7 | % | $ |
73,579
|
28.0 | % | |||||||
Europe
|
79,842
|
30.2 | % |
73,742
|
28.1 | % | |||||||||
Asia
|
113,824
|
43.1 | % |
115,236
|
43.9 | % | |||||||||
Total
sales
|
$ |
264,072
|
100.0 | % | $ |
262,557
|
100.0 | % |
|
·
|
increased
cost of sales of $1.6 million in the three months ended June 30,
2007
associated with share-based compensation expense under the SFAS
123R;
|
|
·
|
fluctuations
in the product mix of microcontrollers, proprietary and non-proprietary
analog products and Serial EEPROM products resulting in lower average
selling prices for our products;
|
|
·
|
lower
depreciation expense as a percentage of cost of sales;
and
|
|
·
|
unfavorable
foreign exchange rate fluctuations impacting our Thailand manufacturing
operations.
|
|
·
|
changes
in capacity utilization and absorption of fixed
costs;
|
|
·
|
gross
profit on products sold through the distribution
channel;
|
|
·
|
continued
cost reductions in wafer fabrication and assembly and test manufacturing
such as new manufacturing technologies and more efficient manufacturing
techniques; and
|
|
·
|
inventory
write-offs and the sale of inventory that was previously written
off.
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market
Risk
|
|
·
|
changes
in demand or market acceptance of our products and products of
our
customers
|
|
·
|
levels
of inventories at our customers
|
|
·
|
the
mix of inventory we hold and our ability to satisfy orders from
our
inventory
|
|
·
|
changes
in utilization of our manufacturing capacity and fluctuations in
manufacturing yields
|
|
·
|
our
ability to secure sufficient assembly and testing
capacity
|
|
·
|
availability
of raw materials and equipment
|
|
·
|
competitive
developments including pricing
pressures
|
|
·
|
the
level of orders that are received and can be shipped in a
quarter
|
|
·
|
the
level of sell-through of our products through
distribution
|
|
·
|
changes
or fluctuations in customer order patterns and
seasonality
|
|
·
|
constrained
availability from other electronic suppliers impacting our customers’
ability to ship their products, which in turn may adversely impact
our
sales to those customers
|
|
·
|
costs
and outcomes of any tax audits or any litigation involving intellectual
property, customers or other issues
|
|
·
|
disruptions
in our business or our customers’ businesses due to terrorist activity,
armed conflict, war, worldwide oil prices and supply, public health
concerns or disruptions in the transportation
system
|
|
·
|
property
damage or other losses which are not covered by
insurance
|
|
·
|
general
economic, industry or political conditions in the United States
or
internationally
|
|
·
|
the
quality, performance, reliability, features, ease of use, pricing
and
diversity of our products
|
|
·
|
our
success in designing and manufacturing new products including those
implementing new technologies
|
|
·
|
the
rate at which customers incorporate our products into their own
applications
|
|
·
|
product
introductions by our competitors
|
|
·
|
the
number, nature and success of our competitors in a given
market
|
|
·
|
our
ability to obtain adequate supplies of raw materials and other
supplies at
acceptable prices
|
|
·
|
our
ability to protect our products and processes by effective utilization
of
intellectual property rights
|
|
·
|
the
quality of our customer service and our ability to address the
needs of
our customers, and
|
|
·
|
general
market and economic conditions.
|
|
·
|
proper
new product selection
|
|
·
|
timely
completion and introduction of new product
designs
|
|
·
|
development
of support tools and collateral literature that make complex new
products
easy for engineers to understand and use,
and
|
|
·
|
market
acceptance of our customers’ end
products.
|
|
·
|
political,
social and economic instability
|
|
·
|
public
health conditions
|
|
·
|
trade
restrictions and changes in tariffs
|
|
·
|
import
and export license requirements and
restrictions
|
|
·
|
difficulties
in staffing and managing international
operations
|
|
·
|
employment
regulations
|
|
·
|
disruptions
in international transport or
delivery
|
|
·
|
fluctuations
in currency exchange rates
|
|
·
|
difficulties
in collecting receivables
|
|
·
|
economic
slowdown in the worldwide markets served by us,
and
|
|
·
|
potentially
adverse tax consequences.
|
|
·
|
quarterly
variations in our operating results and the operating results of
other
technology companies
|
|
·
|
actual
or anticipated announcements of technical innovations or new products
by
us or our competitors
|
|
·
|
changes
in analysts’ estimates of our financial performance or buy/sell
recommendations
|
|
·
|
changes
in our financial guidance or our failure to meet such
guidance
|
|
·
|
general
conditions in the semiconductor industry,
and
|
|
·
|
worldwide
economic and financial conditions.
|
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
32
|
Certification
of Chief Executive Officer and Chief Financial Officer Pursuant
to Section
906 of the Sarbanes-Oxley Act of
2002.
|
MICROCHIP
TECHNOLOGY INCORPORATED
|
|
Date: August
7, 2007
|
By: /s/
Gordon W. Parnell
|
Gordon
W.
Parnell
|
|
Vice
President and Chief
Financial Officer
|
|
(Duly
Authorized Officer,
and
|
|
Principal
Financial
and Accounting Officer)
|